Feinan Lu Author

Jie Chen is Chairman and Chief Scientific Officer at Taimei Intelligence Biopharma R&D, Shanghai, and a Visiting Member of the Center for Innovative Study Design at Stanford University. His extensive experience spans biopharmaceutical research, development, real-world evidence studies, and regulatory submissions.

Naitee Ting is Vice President at StatsVita and serves as Adjunct Professor of Biostatistics at the University of Connecticut, Columbia University, and Colorado State University. He brings decades of experience in clinical trial methodology and pharmaceutical development.

Feinan Lu is Director and Head of Biometrics at Impact Therapeutics, Shanghai. She specializes in the statistical methodology underlying clinical trials and real-world evidence studies supporting regulatory decision-making in drug development.